Changchun hi tech fell more than 8% in intraday diving

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Unpacking China | Key Chinese Firms to Watch This Week （20/09/2026-26/09/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Beyond the Car: China’s Next Wave of Intelligent Hardware

The next chapter for intelligent vehicles is unfolding both inside and beyond the car.

Taobao Takes Double 11 to 20 Overseas Markets, Adding Free Shipping and More Than 1.2 Million Merchants

Taobao plans to run this year’s Double 11 shopping festival across 20 overseas markets, with free-shipping offers in 13 countries and regions and more than 1.2 million Taobao and Tmall merchants participating, the company said on September 21. The campaign extends the platform’s international push beyond small parcels, with furniture and home-improvement goods among the medium and large items it aims to ship directly overseas.

Moonshot AI’s Kimi K3 Joins Amazon Bedrock as Overseas Revenue-Sharing Model Takes Shape

Amazon Web Services announced on September 18 that Kimi K3, developed by China’s Moonshot AI（月之暗面）, is available on Amazon Bedrock, expanding the model’s access to enterprise customers through AWS’s managed AI platform. On September 21, National Business Daily reported that Moonshot had confirmed an overseas cloud revenue-sharing arrangement, adding a commercial dimension to the launch. The financial terms remain undisclosed.